Jeff Knight
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Alx Oncology Holdings Inc (ALXO)
Proxy statement
Current -
Start not stated–2026-04-10
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Crinetics Pharmaceuticals, Inc. (CRNX) | Chief Operating Officer | $511,667 | $3,826,671 |
| 2024 | Crinetics Pharmaceuticals, Inc. (CRNX) | Chief Operating Officer | $490,000 | $4,122,990 |
| 2023 | Crinetics Pharmaceuticals, Inc. (CRNX) | Chief Operating Officer | $459,167 | $2,362,362 |
| 2021 | Crinetics Pharmaceuticals, Inc. (CRNX) | Chief Operating Officer | $136,111 | $2,980,038 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.